Study of LGR5Δ5 Variant in HEK293T Cells
Author Information
Author(s): Kappler Matthias, Thielemann Laura, Glaß Markus, Caggegi Laura, Güttler Antje, Pyko Jonas, Blauschmidt Sarah, Gutschner Tony, Taubert Helge, Otto Sven, Eckert Alexander W., Tavassol Frank, Bache Matthias, Vordermark Dirk, Kaune Tom, Rot Swetlana, Miricescu Daniela
Primary Institution: Martin Luther University Halle-Wittenberg
Hypothesis
How does the differential expression of LGR5 isoforms promote the development of human cancers, particularly regarding the regulation of Wnt/β-catenin activity?
Conclusion
LGR5Δ5 overexpression does not rescue the canonical Wnt pathway without support from LGR4 or LGR5FL, but it influences gene expression related to angiogenesis and collagen regulation.
Supporting Evidence
- LGR5Δ5 does not restore Wnt signaling activity in the absence of LGR4.
- LGR5FL overexpression significantly reduces cell migration.
- RNA sequencing revealed 371 genes deregulated by LGR5Δ5 overexpression.
- LGR5Δ5 enhances radiosensitivity in double-knockout cells.
- RSPO1 expression is upregulated in LGR5Δ5-overexpressing cells.
Takeaway
This study looks at a special version of a protein called LGR5 in cells to see how it affects cancer growth and movement. It found that this version can't help the cells grow like the normal version can, but it does change how some genes work.
Methodology
The study used CRISPR/Cas9 technology to knock out LGR4 and LGR5 in HEK293T cells and analyzed the effects of LGR5Δ5 and LGR5FL overexpression on Wnt signaling and gene expression.
Limitations
The study was conducted in a specific cell line (HEK293T), which may not fully represent the behavior of LGR5Δ5 in other cell types or in vivo.
Statistical Information
P-Value
0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website